Clinical Trial Update: 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma [Phase 3]

View source ↗

Summary

A Phase 3 pivotal trial of recombinant Timothy grass allergen (rPhleum) in adults and adolescents with rhinoconjunctivitis with or without controlled asthma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Rhinoconjunctivitis

Drugs mentioned

• rPhleum (recombinant Phleum pratense allergen)

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Rhinoconjunctivitis, Allergic Asthma | Phase 3 | Status: COMPLETED